Molecular mechanisms of the reversal of imipramine-induced sodium channel blockade by alkalinization in human cardiac myocytes

被引:25
作者
Bou-Abboud, E
Nattel, S
机构
[1] McGill Univ, Dept Med, Inst Cardiol Montreal, Montreal, PQ, Canada
[2] McGill Univ, Univ Montreal, Dept Pharmacol, Montreal, PQ, Canada
[3] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada
关键词
sodium channel; cardiac arrhythmias; local anesthetics; pH; antiarrhythmic drugs;
D O I
10.1016/S0008-6363(98)00011-X
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Alkalinizing agents reverse cardiotoxicity of a variety of sodium channel blockers, including tricyclic antidepressants, but their mechanisms of action are poorly understood. Purpose: To establish the mechanisms by which alkalinization diminishes the sodium channel blocking action of imipramine. Methods: The whole-cell voltage-clamp technique was used to measure I,, during a variety of depolarizing pulse protocols in isolated human atrial myocytes, in the presence and absence of imipramine. A three-state model was used to analyze state-dependent I,, block. Results: Imipramine (1 and 5 mu M) strongly inhibited I,,. Experimental data and piecewise exponential analysis suggested significant binding to both activated and inactivated states. Alkalosis antagonized imipramine-induced I,, blockade by increasing the unbinding rate, with intracellular alkalosis being more effective than extracellular alkalosis. The dissociation constant (K-d) for the inactivated state was increased from 0.55 to 1.40 mu M by extracellular alkalosis and to 2.51 mu M by intracellular alkalosis. Along with the reversal of drug-induced shifts in the inactivation curve, these data indicate that alkalosis on either side of the membrane antagonized drug interactions with the inactivated state. On the other hand, only intracellular alkalosis antagonized activated state block, increasing the K-d from 0.67 mu M to 2.18 mu M, while extracellular alkalosis left the activated state K-d unaltered at 0.67 mu M Conclusions: Alkalinization antagonizes the I-Na-blocking action of imipramine by promoting unbinding from the receptor. Intracellular alkalosis has a particularly important effect related to the activated-state interaction. The lipid-soluble, uncharged moiety appears to be a critical determinant of imipramine's ability to dissociate from the Na+ channel receptor. (C) 1998 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:395 / 404
页数:10
相关论文
共 45 条
[21]   HYPERVENTILATION IN TRICYCLIC ANTI-DEPRESSANT POISONING [J].
KINGSTON, ME .
CRITICAL CARE MEDICINE, 1979, 7 (12) :550-551
[22]   A QUANTITATIVE-ANALYSIS OF THE NA+-DEPENDENCE OF VMAX OF THE FAST ACTION-POTENTIAL IN MAMMALIAN VENTRICULAR MYOCARDIUM - SATURATION CHARACTERISTICS AND THE MODULATION OF A DRUG-INDUCED INA BLOCKADE BY [NA+]O [J].
KOHLHARDT, M .
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 1982, 392 (04) :379-387
[23]   ELECTRO-PHYSIOLOGICAL EFFECTS OF IMIPRAMINE IN NON-TREATED AND IN IMIPRAMINE-PRETREATED RAT ATRIAL FIBERS [J].
MANZANARES, J ;
TAMARGO, J .
BRITISH JOURNAL OF PHARMACOLOGY, 1983, 79 (01) :167-175
[24]  
MARSHALL JB, 1982, AM HEART J, V103, P401, DOI 10.1016/0002-8703(82)90281-2
[26]  
MOORMAN JR, 1986, J PHARMACOL EXP THER, V238, P159
[27]   PH-DEPENDENT BINDING OF LOCAL-ANESTHETICS IN SINGLE BATRACHOTOXIN-ACTIVATED NA+ CHANNELS - COCAINE VS QUATERNARY COMPOUNDS [J].
NETTLETON, J ;
WANG, GK .
BIOPHYSICAL JOURNAL, 1990, 58 (01) :95-106
[28]   BLOCK OF SODIUM-CHANNELS BY PSYCHOTROPIC-DRUGS IN SINGLE GUINEA-PIG CARDIAC MYOCYTES [J].
OGATA, N ;
NARAHASHI, T .
BRITISH JOURNAL OF PHARMACOLOGY, 1989, 97 (03) :905-913
[29]   EXTERNAL PH MODIFIES SODIUM-CHANNEL BLOCK BY MEXILETINE IN GUINEA-PIG VENTRICULAR MYOCYTES [J].
ONO, M ;
SUNAMI, A ;
SAWANOBORI, T ;
HIRAOKA, M .
CARDIOVASCULAR RESEARCH, 1994, 28 (07) :973-979
[30]   CHARACTERIZATION OF CONCENTRATION-DEPENDENT AND USE-DEPENDENT EFFECTS OF QUINIDINE FROM CONDUCTION DELAY AND DECLINING CONDUCTION-VELOCITY IN CANINE PURKINJE-FIBERS [J].
PACKER, DL ;
GRANT, AO ;
STRAUSS, HC ;
STARMER, CF .
JOURNAL OF CLINICAL INVESTIGATION, 1989, 83 (06) :2109-2119